Literature DB >> 16791038

Negative effect of immediate hyperbaric oxygen therapy in acute acoustic trauma.

Burak Omür Cakir1, Ibrahim Ercan, Senol Civelek, Sefika Körpinar, Akýn Savaş Toklu, Ozlem Gedik, Gökhan Işik, Ibrahim Sayin, Suat Turgut.   

Abstract

OBJECTIVE: The functional evaluation of the effect of the hyperbaric oxygen therapy (HBOT) onset time on cochlea by using distortion product otoacoustic emission. STUDY
DESIGN: Animal study.
METHODS: Twenty-four Wistar albino rats were divided into six groups and their right ears were directly exposed to a 110-dB sound pressure level (1-12 kHz) white noise for 25 minutes. The first group was considered the control group. HBOT was started at 1 hour postexposure for the second group, at 2 hours postexposure for the third group, at 6 hours postexposure for the fourth group, at 24 hours postexposure for the fifth group, and at 48 hours postexposure for the sixth group. Signal-to-noise ratios (SNRs) were recorded before the noise exposure; immediately after the noise exposure; and on the 3rd, 7th, and 10th day of postexposure.
RESULTS: SNRs at 6 to 8 kHz were significantly decreased after the acoustic trauma. The evaluation on the third day of postexposure showed that recovery begun in all groups except the group in which the HBOT was started at 1 hour postexposure. SNRs in the control group and HBOT groups were back to the preexposure levels at 10 days postexposure, except the 1- and 2-hour postexposure groups. However, in the group in which the HBOT was started at 1 hour postexposure, distortion product otoacoustic emissions were lost except at 4 kHz. The recovery of the SNRs in hyperbaric oxygen administration at 2 hours postexposure almost completed on the 10th day after noise exposure.
CONCLUSION: Immediate HBOT in acoustic trauma treatment is not necessary; on the contrary, it has an adverse effect.

Entities:  

Mesh:

Year:  2006        PMID: 16791038     DOI: 10.1097/01.mao.0000224080.77849.3d

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  7 in total

1.  Effects of hyperbaric oxygen treatment on auditory hair cells after acute noise damage.

Authors:  Gleice Cristina Colombari; Maria Rossato; Omar Feres; Miguel Angelo Hyppolito
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-07-21       Impact factor: 2.503

2.  The effect of active sonar for the protection of moored and anchored warships on the human hearing.

Authors:  Angelo Salami; Massimo Dellepiane; Mauro Barbierato; Pierluigi Freda; Barbara Crippa; Luca Guastini; Renzo Mora
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-12       Impact factor: 2.503

3.  The Use of Hyperbaric Oxygen Therapy and Corticosteroid Therapy in Acute Acoustic Trauma: 15 Years' Experience at the Czech Military Health Service.

Authors:  Richard Holy; Sarka Zavazalova; Klara Prochazkova; David Kalfert; Temoore Younus; Petr Dosel; Daniel Kovar; Karla Janouskova; Boris Oniscenko; Zdenek Fik; Jaromir Astl
Journal:  Int J Environ Res Public Health       Date:  2021-04-22       Impact factor: 3.390

4.  Hyperbaric oxygen upregulates cochlear constitutive nitric oxide synthase.

Authors:  Chia-Der Lin; I-Hua Wei; Chih-Ho Lai; Te-Chun Hsia; Ming-Ching Kao; Ming-Hsui Tsai; Ching-Hsiang Wu; Mang-Hung Tsai
Journal:  BMC Neurosci       Date:  2011-02-22       Impact factor: 3.288

Review 5.  Use of Gases to Treat Cochlear Conditions.

Authors:  Jay C Buckey
Journal:  Front Cell Neurosci       Date:  2019-04-24       Impact factor: 5.505

6.  It's all about timing, early treatment with hyperbaric oxygen therapy and corticosteroids is essential in acute acoustic trauma.

Authors:  A B Bayoumy; R P Weenink; E L van der Veen; F S Besseling-Hansen; A D M Hoedemaeker; F J M de Jong; M H van der Laan; R Swenker; R A van Hulst; J A de Ru
Journal:  J Otol       Date:  2021-05-11

7.  Effects of Oxygen Therapies in Experimental Acute Acoustic Trauma.

Authors:  Nazim Ata; Erkan Kahraman; Armagan Incesulu; Engin Yildirim
Journal:  J Int Adv Otol       Date:  2021-11       Impact factor: 1.017

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.